Login/Sign Up
₹17900
(Inclusive of all Taxes)
₹2685.0 Cashback (15%)
Provide Delivery Location
Online payment accepted
Whats That
About Cizumab 300 Injection 12 ml
Cizumab 300 Injection 12 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.
Cizumab 300 Injection 12 ml contains 'Bevacizumab' that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.
Cizumab 300 Injection 12 ml will be administered by a healthcare professional; do not self-administer. Based on your medical condition, your doctor will decide the dose and duration. In some cases, Cizumab 300 Injection 12 ml may cause loss of appetite, constipation, fever, nosebleeds, change in speech, and taste. The majority of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen
Avoid taking Cizumab 300 Injection 12 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Cizumab 300 Injection 12 ml may cause sleepiness and fainting, so avoid driving while on treatment with Cizumab 300 Injection 12 ml. Do not breastfeed during the treatment and for 6months after the last dose of Cizumab 300 Injection 12 ml. Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects.
Uses of Cizumab 300 Injection 12 ml
Directions for Use
Medicinal Benefits
Cizumab 300 Injection 12 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cizumab 300 Injection 12 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.
Storage
Drug Warnings
Cizumab 300 Injection 12 ml should only be taken under medical supervision. While taking Cizumab 300 Injection 12 ml, the doctor will monitor your condition on a regular basis. If you have a history of allergic reactions to Cizumab 300 Injection 12 ml or other medications, inform your doctor before taking it. Avoid taking Cizumab 300 Injection 12 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Cizumab 300 Injection 12 ml may cause sleepiness and fainting, so avoid driving while on treatment with Cizumab 300 Injection 12 ml. Inform your doctor if you have/had high blood pressure, heart attack, stroke, bleeding problems, stomach/intestinal bleeding, perforation; if you had surgery in the past 28days/are due to have surgery. Do not breastfeed during the treatment and for 6months after the last dose of Cizumab 300 Injection 12 ml. While taking Cizumab 300 Injection 12 ml, please do not get any immunizations or vaccinations unless your doctor has approved it. Cizumab 300 Injection 12 ml may increase the risk of bleeding, so be cautious and consult your doctor if you notice any bleeding or bruising.
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Cizumab 300 Injection 12 ml works against a protein called vascular endothelial growth factor (VEGF). Inhibition of vascular endothelial growth factor (VEGF) limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thereby, Cizumab 300 Injection 12 ml helps treat cancer.
Cizumab 300 Injection 12 ml may reduce the number of red blood cells leading to anaemia. Its symptoms include pale skin, lack of energy, feeling breathless, feeling dizzy and lightheadedness.
Chemotherapy remains necessary. Cizumab 300 Injection 12 ml is given along with chemotherapy for treating cancer.
Cizumab 300 Injection 12 ml may increase the risk of bleeding and problems with wound healing. If you have had major surgery in the past 28days or if the wound hasn't healed, you should not take Cizumab 300 Injection 12 ml. Talk to your doctor for more information.
Cancer can affect anyone, though the risk increases with age. Individual risk is determined by factors such as smoking and drinking habits, lifestyle choices such as what you eat and exercise; a family history of cancer, and factors in your workplace and environment.
Cizumab 300 Injection 12 ml may increase the incidence of hypertension. Therefore, consult your doctor before taking Cizumab 300 Injection 12 ml if you have high blood pressure.
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Cancer: It is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one part of the body and spreads to other areas. It occurs due to mutations in genes that regulate cell growth. The mutations cause the cells to divide and multiply in an uncontrolled manner, leading to tumour formation. The most common cancer treatment methods are surgery, chemotherapy, radiotherapy, bone marrow (stem cell) transplantation, immunotherapy, and targeted drug therapy.
Have a query?